ArticleMedicine2026
Exploring significant gender disparities in esophageal cancer risk: Insights from Mendelian randomization analysis and global burden of disease data.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Esophageal cancer (EC) is responsible for approximately 508,000 deaths worldwide each year. Emerging evidence suggests significant gender disparities in EC-related mortality. This study aims to explore the underlying causes of these differences. In this study, global mortality rates of EC were obtained from the global burden of disease database. Several factors strongly associated with EC risk were identified and treated as exposures. Mendelian randomization analysis was then conducted to evaluate the potential causal relationships between EC risk and testosterone levels (TLs), body mass index, smoking, alcohol consumption, red meat intake, and vegetable consumption. The results showed that higher TLs (P = .03; beta = 0.07; 95% confidence interval, 0.006-0.13) and smoking (P = .03; beta = 0.39; 95% confidence interval, 0.02-0.78) were significantly and positively associated with an increased risk of EC. No causal associations were observed between EC risk and the other investigated factors. Survival analysis revealed that PTEN and PIK3CA proteins had no statistically significant impact on the survival of EC patients (PTEN: Log-rank P = .89, HR = 1.1; PIK3CA: Log-rank P = .97, HR = 0.99). Meanwhile, TP53 protein suggested a potential adverse effect on survival (Log-rank P = .057, HR = 2.5). Significant gender disparities in the risk of EC may be attributed to the direct causal effects of smoking and elevated TLs in males. In contrast, factors such as alcohol consumption, body mass index, and dietary habits do not appear to have a significant impact on EC risk. It was also observed that the causal relationship between TLs and the risk of EC may be mediated by the TP53 protein.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.